Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Surveys and Questionnaires × Myeloid × Clear all

Status

Completed 4 Unknown 3 Terminated 3 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 16 Gastrointestinal 12 Head & Neck 8 Gynecologic 8 Genitourinary 7 CNS 5 Thoracic 4 Tumor-Agnostic 3 Plasma cell 2 Other solid neoplasm 2 Other hematologic neoplasm 2 Lymphoid 2 Other neoplasm 1 Other 1 Myeloid 1 Endocrine 1 Dermatologic 1

Conditions

Myeloproliferative Disorders 1

Interventions

Cyclophosphamide 22 fludarabine 21 fludarabine phosphate 18 venetoclax 15 Tacrolimus 15 Melphalan 14 Azacitidine 14 ruxolitinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 Busulfan 12 Cytarabine 10 Specimen Handling 9 Decitabine 9 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 8 Biopsy 8 Stem Cell Transplantation 7 Granulocyte Colony-Stimulating Factor 7 decitabine and cedazuridine drug combination 6 asciminib 6 Sirolimus 6 Methotrexate 6 thymoglobulin 5 X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Injections 5 Imatinib Mesylate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04378855 2025-09-23

PROPHECY

Gruppo Italiano Malattie EMatologiche dell'Adulto

Active not recruiting

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡